Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to understand the real-world clinical outcomes and treatment patterns of adults with obstructive hypertrophic cardiomyopathy (HCM) treated with mavacamten, and to understand patient and physician experiences with mavacamten treatment, in the US community-based practice
Official title: Mavacamten Real-World OutcomeS and the Associated PAtient and Physician ExpeRienCe With Hypertrophic CardioMyopathy in the United States (US) Community
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
362
Start Date
2026-01-15
Completion Date
2027-06-17
Last Updated
2026-04-29
Healthy Volunteers
No
Interventions
Mavacamten
According to the product label
Locations (1)
Adelphi Real World
Bollington, Macclesfield, United Kingdom